Divi's Laboratories is currently trading at Rs. 4334.10, up by 20.70 points or 0.48% from its previous closing of Rs. 4313.40 on the BSE.
The scrip opened at Rs. 4300.55 and has touched a high and low of Rs. 4475.00 and Rs. 4240.60 respectively.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 5,425.00 on 18-Oct-2021 and a 52 week low of Rs. 3,154.50 on 19-March-2021.
Last one week high and low of the scrip stood at Rs. 4475.00 and Rs. 4164.95 respectively. The current market cap of the company is Rs. 1,15,056.74 crore.
Divi's Laboratories has reported a rise of 96.69% in its net profit at Rs 907.22 crore for the quarter ended December 31, 2021 as compared to Rs 461.24 crore for the same quarter in the previous year. Total income of the company increased by 48.16% at Rs 2,483.39 crore for Q3FY22 as compared Rs 1,676.16 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 91.71% in its net profit at Rs 902.24 crore for the quarter ended December 31, 2021 as compared to Rs 470.62 crore for the same quarter in the previous year. Total income of the company increased by 45.86% at Rs 2,509.86 crore for Q3FY22 as compared Rs 1,720.76 crore for the corresponding quarter previous year.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: